Abnormal human chorionic gonadotropin levels and normal pregnancy outcomes in the ovarian hyperstimulation syndrome

J Reprod Med. 2004 Jan;49(1):8-12.

Abstract

Objective: To validate whether abnormally rising human chorionic gonadotropin (hCG) levels, in the presence of the ovarian hyperstimulation syndrome (OHSS), may serve to diagnose abnormal gestation.

Study design: In an observational, case-control study, the rates of hCG rise after treatment with gonadotropins or assisted reproductive technologies were compared. Cases consisted of 9 women with OHSS. Controls (121 subjects) were matched except that they did not have OHSS. The significance of differences in the slope of the hCG rise was determined by t testing.

Results: The average doubling time for hCG was 50.4 hours for cases and 38.0 for controls. The slopes of the hCG rise between the groups differed significantly (P = .0015). Pregnancy outcomes were normal for all patients.

Conclusion: Abnormally rising hCG levels do not predict poor outcome in pregnancies complicated by OHSS and therefore are not helpful in the decision-making process to diagnose ectopic or otherwise compromised pregnancies.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Female
  • Humans
  • Ovarian Hyperstimulation Syndrome / blood
  • Ovarian Hyperstimulation Syndrome / etiology*
  • Ovulation Induction / adverse effects*
  • Pregnancy
  • Pregnancy Complications*
  • Pregnancy Outcome

Substances

  • Chorionic Gonadotropin, beta Subunit, Human